BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Vivanza Biosciences Ltd Industry :  Trading
BSE Code
530057
ISIN Demat
INE984E01035
Book Value (Rs)
1.1
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
8
P/E (TTM)
14.62
EPS (TTM)
0.13
Face Value
(Rs)
1
Back
Vivanza Biosciences consolidated net profit rises 66.67% in the June 2026 quarter
07-Aug-26   Hrs IST

Net profit of Vivanza Biosciences rose 66.67% to Rs 0.15 crore in the quarter ended June 2026 as against Rs 0.09 crore during the previous quarter ended June 2025. Sales rose 3.91% to Rs 9.29 crore in the quarter ended June 2026 as against Rs 8.94 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales9.298.94 4
OPM %-0.861.68 -
PBDT0.190.09 111
PBT0.180.09 100
NP0.150.09 67

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)